VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New US Patent on Methods for Producing Blood Cells … – Marketwired (press release)
|
VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New US Patent on Methods for Producing Blood Cells …
Marketwired (press release) SOUTH SAN FRANCISCO, CA–(Marketwired – December 08, 2017) – VistaGen Therapeutics Inc. ( NASDAQ : VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS … |
